CARECLOUD INC (MTBC) Stock Fundamental Analysis

NASDAQ:MTBC • US14167R1005

3.13 USD
+0.34 (+12.19%)
Last: Jan 9, 2023, 08:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MTBC. MTBC was compared to 35 industry peers in the Health Care Technology industry. The financial health of MTBC is average, but there are quite some concerns on its profitability. MTBC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MTBC had negative earnings in the past year.
  • MTBC had a positive operating cash flow in the past year.
MTBC Yearly Net Income VS EBIT VS OCF VS FCFMTBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M -20M

1.2 Ratios

  • The profitability ratios for MTBC are negative, so there is not much use analyzing them.
  • MTBC has a Return On Invested Capital of 4.81%. This is amongst the best in the industry. MTBC outperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 4.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTBC Yearly ROA, ROE, ROICMTBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

  • MTBC has a better Operating Margin (3.77%) than 77.78% of its industry peers.
  • Looking at the Gross Margin, with a value of 38.04%, MTBC is doing worse than 62.22% of the companies in the same industry.
  • MTBC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.77%
PM (TTM) N/A
GM 38.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
MTBC Yearly Profit, Operating, Gross MarginsMTBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTBC is destroying value.
  • Compared to 1 year ago, MTBC has more shares outstanding
  • MTBC has a worse debt/assets ratio than last year.
MTBC Yearly Shares OutstandingMTBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M
MTBC Yearly Total Debt VS Total AssetsMTBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M

2.2 Solvency

  • MTBC has an Altman-Z score of 2.01. This is not the best score and indicates that MTBC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.01, MTBC is doing good in the industry, outperforming 62.22% of the companies in the same industry.
  • The Debt to FCF ratio of MTBC is 0.06, which is an excellent value as it means it would take MTBC, only 0.06 years of fcf income to pay off all of its debts.
  • MTBC has a better Debt to FCF ratio (0.06) than 86.67% of its industry peers.
  • MTBC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • MTBC has a Debt to Equity ratio of 0.00. This is in the better half of the industry: MTBC outperforms 68.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 2.01
ROIC/WACC0.61
WACC7.84%
MTBC Yearly LT Debt VS Equity VS FCFMTBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • MTBC has a Current Ratio of 1.21. This is a normal value and indicates that MTBC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.21, MTBC is not doing good in the industry: 68.89% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.19 indicates that MTBC should not have too much problems paying its short term obligations.
  • MTBC has a worse Quick ratio (1.19) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.19
MTBC Yearly Current Assets VS Current LiabilitesMTBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • MTBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.73%, which is quite impressive.
  • MTBC shows a small growth in Revenue. In the last year, the Revenue has grown by 7.14%.
  • MTBC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.63% yearly.
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%

3.2 Future

  • Based on estimates for the next years, MTBC will show a small growth in Earnings Per Share. The EPS will grow by 6.25% on average per year.
  • The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTBC Yearly Revenue VS EstimatesMTBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MTBC Yearly EPS VS EstimatesMTBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MTBC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MTBC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTBC Price Earnings VS Forward Price EarningsMTBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MTBC is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • 97.78% of the companies in the same industry are more expensive than MTBC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.4
EV/EBITDA 2.55
MTBC Per share dataMTBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MTBC's earnings are expected to grow with 16.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MTBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CARECLOUD INC

NASDAQ:MTBC (1/9/2023, 8:23:58 PM)

3.13

+0.34 (+12.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03
Earnings (Next)03-13
Inst Owners11.55%
Inst Owner Change20.35%
Ins Owners0.89%
Ins Owner Change0%
Market Cap47.61M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target9.69 (209.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.54%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF 5.4
P/OCF 2.24
P/B 0.46
P/tB 4.01
EV/EBITDA 2.55
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY18.5%
OCF(TTM)1.4
OCFY44.58%
SpS9.45
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 4.81%
ROICexc 4.99%
ROICexgc 43.34%
OM 3.77%
PM (TTM) N/A
GM 38.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0.03
Cap/Depr 103.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.19
Altman-Z 2.01
F-Score4
WACC7.84%
ROIC/WACC0.61
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A

CARECLOUD INC / MTBC FAQ

Can you provide the ChartMill fundamental rating for CARECLOUD INC?

ChartMill assigns a fundamental rating of 3 / 10 to MTBC.


What is the valuation status for MTBC stock?

ChartMill assigns a valuation rating of 3 / 10 to CARECLOUD INC (MTBC). This can be considered as Overvalued.


How profitable is CARECLOUD INC (MTBC) stock?

CARECLOUD INC (MTBC) has a profitability rating of 1 / 10.


Can you provide the financial health for MTBC stock?

The financial health rating of CARECLOUD INC (MTBC) is 4 / 10.


What is the earnings growth outlook for CARECLOUD INC?

The Earnings per Share (EPS) of CARECLOUD INC (MTBC) is expected to grow by 13.69% in the next year.